Aspen Pharmacare Holdings (APN.JO) Akcija Cena
Aspen Pharmacare Holdings Cena
Pēdējos 19 gados Aspen Pharmacare Holdings ieņēmumi auga par 12,0 % gadā un sasniedza 34,87 B ZAR. Peļņa uz akciju auga par 6,1 % gadā pēdējos 19 gados. Aspen Pharmacare Holdings neto marža 7,6 % ir samazinājusies salīdzinājumā ar 16,8 % pirms dažiem gadiem. Pie šodienas cenas dividenžu ienesīgums ir aptuveni 1,28 %. Izmaksas koeficients ir ap 28 % no peļņas. Dividendes auga par 6,1 % gadā pēdējos 19 gados. Aspen Pharmacare Holdings 12 mēnešu konsensa mērķa cena ir 117,30 ZAR, ap zem kursu par 28,7 %. No 10 analītiķiem 0 iesaka pirkt — kopējais konsenss ir Turēt.
Aspen Pharmacare Holdings akcijas cena
Iegūstiet šos datus caur Eulerpool API
100 000 pieprasījumu/mēn. bez maksas · bez kartes
Aspen Pharmacare Holdings biznesa modelis un akciju analīze
Bieži uzdotie jautājumi par Aspen Pharmacare Holdings akciju
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Analītiķi pašlaik nosaka vidējo Aspen Pharmacare Holdings akcijas mērķa cenu 120,02 ZAR (mediāna: 117,30 ZAR), kas ir -27,0 % pret pēdējo cenu. Konsenss balstās uz 10 analītiķu vērtējumiem.
10 analītiķi pašlaik vērtē Aspen Pharmacare Holdings akciju: 0 iesaka pirkt, 6 turēt un 4 pārdot.
Pēc pašreizējā kursa Aspen Pharmacare Holdings akcija maksā 8,91 EUR (164,45 ZAR).
Aspen Pharmacare Holdings akcija (APN.JO) tiek kotēta 5 biržās, tostarp: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
apgrozījums Aspen Pharmacare Holdings ir 34,87 B ZAR. Šis skaitlis ir balstīts uz pašreizējiem finanšu datiem un atspoguļo uzņēmuma biznesa sniegumu.
peļņa Aspen Pharmacare Holdings ir 2,65 B ZAR. Neto peļņa atspoguļo uzņēmuma rentabilitāti pēc visu izdevumu atskaitīšanas.
Aspen Pharmacare Holdings cenas un peļņas rādītājs (P/E) pašlaik ir 27,55. P/E rādītājs salīdzina pašreizējo akcijas cenu ar peļņu uz akciju un palīdz ieguldītājiem novērtēt Aspen Pharmacare Holdings akcijas vērtību.
Aspen Pharmacare Holdings cenas un apgrozījuma rādītājs (P/S) pašlaik ir 2,09. P/S rādītājs salīdzina tirgus kapitalizāciju ar gada apgrozījumu un kalpo kā Aspen Pharmacare Holdings akcijas vērtības mērs.
Aspen Pharmacare Holdings Eulerpool kvalitātes rādītājs ir 1/10.
Aspen Pharmacare Holdings ISIN ir ZAE000066692. ISIN (International Securities Identification Number) ir pasaulē unikāls vērtspapīru identifikators.
Aspen Pharmacare Holdings WKN ir A0ET80. WKN (Wertpapierkennnummer) ir sešciparu vācu vērtspapīru identifikācijas numurs.
Aspen Pharmacare Holdings tikeris ir APN.JO. Tikeris tiek izmantots Aspen Pharmacare Holdings akciju tirdzniecībai biržā.
Aspen Pharmacare Holdings akcija
Aspen Pharmacare Holdings Salīdzināmo uzņēmumu grupa
Aspen Pharmacare Holdings Biržas kods
Aspen Pharmacare Holdings FIGI
Visi Aspen Pharmacare Holdings fundamentālie rādītāji un padziļinātā analīze
Mūsu akciju analīze par Aspen Pharmacare Holdings ietver svarīgus finanšu rādītājus, piemēram, apgrozījumu, peļņu, P/E rādītāju, P/S rādītāju, EBIT, kā arī informāciju par dividendēm. Turklāt mēs aplūkojam aspektus kā akcijas, tirgus kapitalizāciju, parādus, pašu kapitālu un saistības no Aspen Pharmacare Holdings. Ja meklējat sīkāku informāciju par šīm tēmām, piedāvājam detalizētas analīzes mūsu apakšlapās: